{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:12:26Z","timestamp":1790784746555,"version":"4.1.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1038\/s41433-026-04269-8","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T06:41:13Z","timestamp":1770619273000},"page":"797-804","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prevalence and associations of central serous chorioretinopathy in a population aged 50+ years. The Beijing Eye Study"],"prefix":"10.1038","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2972-5227","authenticated-orcid":false,"given":"Jost B.","family":"Jonas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songhomitra","family":"Panda-Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2039-7055","authenticated-orcid":false,"given":"Jie","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5389-3047","authenticated-orcid":false,"given":"Rahul A.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2749-7793","authenticated-orcid":false,"given":"Ya Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,9]]},"reference":[{"key":"4269_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/ceo.14201","volume":"51","author":"AT Fung","year":"2023","unstructured":"Fung AT, Yang Y, Kam AW. Central serous chorioretinopathy: a review. Clin Exp Ophthalmol. 2023;51:243\u201370.","journal-title":"Clin Exp Ophthalmol"},{"key":"4269_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-vision-102122-102907","volume":"10","author":"AH Khan","year":"2024","unstructured":"Khan AH, Lotery AJ. Central serous chorioretinopathy: epidemiology, genetics and clinical features. Annu Rev Vis Sci. 2024;10:477\u2013505.","journal-title":"Annu Rev Vis Sci"},{"key":"4269_CR3","doi-asserted-by":"publisher","first-page":"100865","DOI":"10.1016\/j.preteyeres.2020.100865","volume":"79","author":"R Kaye","year":"2020","unstructured":"Kaye R, Chandra S, Sheth J, Boon CJF, Sivaprasad S, Lotery A. Central serous chorioretinopathy: an update on risk factors, pathophysiology and imaging modalities. Prog Retin Eye Res. 2020;79:100865.","journal-title":"Prog Retin Eye Res"},{"key":"4269_CR4","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1136\/bjophthalmol-2021-319403","volume":"106","author":"A Kido","year":"2022","unstructured":"Kido A, Miyake M, Tamura H, Hiragi S, Kimura T, Ohtera S, et al. Incidence of central serous chorioretinopathy (2011-2018): a nationwide population-based cohort study of Japan. Br J Ophthalmol. 2022;106:1748\u201353.","journal-title":"Br J Ophthalmol"},{"key":"4269_CR5","doi-asserted-by":"publisher","unstructured":"Fakhril-Din Z, Arnold-Vangsted A, Boberg-Ans LC, Anguita R, Desideri LF, van Dijk EHC, et al. Is tobacco consumption a risk factor for central serous chorioretinopathy? A systematic review and meta-analysis. Acta Ophthalmol. 2024 Oct 18. https:\/\/doi.org\/10.1111\/aos.16782. Online ahead of print.","DOI":"10.1111\/aos.16782"},{"key":"4269_CR6","first-page":"2749296","volume":"2019","author":"YY Chen","year":"2019","unstructured":"Chen YY, Huang LY, Liao WL, Chou P. Association between central serous chorioretinopathy and risk of depression: a population-based cohort study. J Ophthalmol. 2019;2019:2749296.","journal-title":"J Ophthalmol"},{"key":"4269_CR7","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/S0161-6420(02)01117-X","volume":"109","author":"CA Carvalho-Recchia","year":"2002","unstructured":"Carvalho-Recchia CA, Yannuzzi LA, Negr\u00e3o S, Spaide RF, Freund KB, Rodriguez-Coleman H, et al. Corticosteroids and central serous chorioretinopathy. Ophthalmology. 2002;109:1834\u20137.","journal-title":"Ophthalmology"},{"key":"4269_CR8","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/j.oret.2022.04.015","volume":"6","author":"HG Kang","year":"2022","unstructured":"Kang HG, Woo SJ, Lee JY, Cho HJ, Ahn J, Yang YS, et al. Pathogenic risk factors and associated outcomes in the bullous variant of central serous chorioretinopathy. Ophthalmol Retina. 2022;6:939\u201348.","journal-title":"Ophthalmol Retina"},{"key":"4269_CR9","doi-asserted-by":"publisher","first-page":"5099","DOI":"10.3390\/ijerph16245099","volume":"16","author":"CC Hsu","year":"2019","unstructured":"Hsu CC, Chen YH, Huang KH, Chen J, Chung CH, Liang CM, et al. The correlation of central serous chorioretinopathy and subsequent cardiovascular diseases of different types: a population-based cohort study. Int J Environ Res Public Health. 2019;16:5099.","journal-title":"Int J Environ Res Public Health"},{"key":"4269_CR10","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1097\/IAE.0000000000002702","volume":"40","author":"PK Liu","year":"2020","unstructured":"Liu PK, Chang YC, Tai MH, Tsai RK, Chong IW, Wu KY, et al. the association between central serious chorioretinopathy and sleep apnea: a nationwide population-based study. Retina. 2020;40:2034\u201344.","journal-title":"Retina"},{"key":"4269_CR11","doi-asserted-by":"publisher","first-page":"e14859","DOI":"10.1097\/MD.0000000000014859","volume":"98","author":"YS Chang","year":"2019","unstructured":"Chang YS, Weng SF, Wang JJ, Jan RL. Increased risk of central serous chorioretinopathy following end-stage renal disease: a nationwide population-based study. Medicine. 2019;98:e14859.","journal-title":"Medicine"},{"key":"4269_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1097\/JCMA.0000000000000533","volume":"84","author":"CC Hsu","year":"2021","unstructured":"Hsu CC, Chen YH, Huang KH, Chen J, Chung CH, Liang CM, et al. Evaluation of the relationship between central serous chorioretinopathy and liver cirrhosis: a nationwide, population-based study. J Chin Med Assoc. 2021;84:655\u201363.","journal-title":"J Chin Med Assoc"},{"key":"4269_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ajo.2022.08.002","volume":"244","author":"FC Piccolino","year":"2022","unstructured":"Piccolino FC, Fruttini D, Eandi C, Nicol\u00f2 M, Mariotti C, Tito S, et al. Vigorous physical activity as a risk factor for central serous chorioretinopathy. Am J Ophthalmol. 2022;244:30\u201337.","journal-title":"Am J Ophthalmol"},{"key":"4269_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100201","volume":"2","author":"M Yagi","year":"2022","unstructured":"Yagi M, Miyake M, Mori Y, Hosoda Y, Takahashi A, Muraoka Y, et al. Natural course of pachychoroid pigment epitheliopathy. Ophthalmol Sci. 2022;2:100201.","journal-title":"Ophthalmol Sci"},{"key":"4269_CR15","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.1007\/s00417-023-06201-2","volume":"261","author":"YT Huang","year":"2023","unstructured":"Huang YT, Wan L, Cheng YD, Yu TS, Hung YT, Rujikajorn K, et al. Increased risk of glaucoma development in patients with central serous chorioretinopathy: results of a 11-year population-based cohort study. Graefes Arch Clin Exp Ophthalmol. 2023;261:3457\u201364.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"4269_CR16","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1097\/IAE.0000000000003485","volume":"42","author":"RF Spaide","year":"2022","unstructured":"Spaide RF, Fisher YL, Ngo WK, Barbazetto I. Regional scleral thickness as a risk factor for central serous chorioretinopathy. Retina. 2022;42:1231\u20137.","journal-title":"Retina"},{"key":"4269_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.100973","volume":"86","author":"RF Spaide","year":"2022","unstructured":"Spaide RF, Gemmy Cheung CM, Matsumoto H, Kishi S, Boon CJF, van Dijk EHC, et al. Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders. Prog Retin Eye Res. 2022;86:100973.","journal-title":"Prog Retin Eye Res"},{"key":"4269_CR18","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.oret.2020.07.011","volume":"5","author":"N Imanaga","year":"2021","unstructured":"Imanaga N, Terao N, Nakamine S, Tamashiro T, Wakugawa S, Sawaguchi K, et al. Scleral thickness in central serous chorioretinopathy. Ophthalmol Retina. 2021;5:285\u201391.","journal-title":"Ophthalmol Retina"},{"key":"4269_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.64.1.16","volume":"64","author":"N Imanaga","year":"2023","unstructured":"Imanaga N, Terao N, Sonoda S, Sawaguchi S, Yamauchi Y, Sakamoto T, et al. Relationship between scleral thickness and choroidal structure in central serous chorioretinopathy. Investig Ophthalmol Vis Sci. 2023;64:16.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4269_CR20","doi-asserted-by":"publisher","unstructured":"Jonas JB, Panda-Jonas S, Xu J, Jonas RA, Wang YX. Prevalence and associations of the three-layer sign in age-related macular degeneration. The Beijing eye study. Acta Ophthalmol. 2025 Sep 19. https:\/\/doi.org\/10.1111\/aos.70004. Online ahead of print. PMID: 40970575","DOI":"10.1111\/aos.70004"},{"key":"4269_CR21","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1167\/iovs.13-13351","volume":"55","author":"JB Jonas","year":"2014","unstructured":"Jonas JB, Wang N, Wang YX, You QS, Xie XB, Yang D, et al. Subfoveal choroidal thickness and cerebrospinal fluid pressure. The Beijing Eye Study 2011. Investig Ophthalmol Vis Sci. 2014;55:1292\u20138.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"4269_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.ophtha.2007.02.032","volume":"115","author":"AS Kitzmann","year":"2008","unstructured":"Kitzmann AS, Pulido JS, Diehl NN, Hodge DO, Burke JP. The incidence of central serous chorioretinopathy in Olmsted County, Minnesota, 1980\u20132002. Ophthalmology. 2008;115:169\u201373.","journal-title":"Ophthalmology"},{"key":"4269_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/S0161-6420(92)32010-X","volume":"99","author":"H Schatz","year":"1992","unstructured":"Schatz H, Madeira D, Johnson RN, McDonald HR. Central serous chorioretinopathy occurring in patients 60 years of age and older. Ophthalmology. 1992;99:63\u201367.","journal-title":"Ophthalmology"},{"key":"4269_CR24","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0161-6420(96)30386-2","volume":"103","author":"RF Spaide","year":"1996","unstructured":"Spaide RF, Campeas L, Haas A, Yannuzzi LA, Fisher YL, Guyer DR, et al. Central serous chorioretinopathy in younger and older adults. Ophthalmology. 1996;103:2070\u20139.","journal-title":"Ophthalmology"},{"key":"4269_CR25","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.survophthal.2012.07.004","volume":"58","author":"B Nicholson","year":"2013","unstructured":"Nicholson B, Noble J, Forooghian F, Meyerle C. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol. 2013;58:103\u201326.","journal-title":"Surv Ophthalmol"},{"key":"4269_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S0008-4182(02)80043-6","volume":"37","author":"KC Todd","year":"2002","unstructured":"Todd KC, Hainsworth DP, Lee LR, Madsen RW. Longitudinal analysis of central serous chorioretinopathy and sex. Can J Ophthalmol. 2002;37:405\u20138.","journal-title":"Can J Ophthalmol"},{"key":"4269_CR27","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1136\/bjophthalmol-2018-312431","volume":"103","author":"MG Ersoz","year":"2019","unstructured":"Ersoz MG, Arf S, Hocaoglu M, Sayman Muslubas I, Karacorlu M. Patient characteristics and risk factors for central serous chorioretinopathy: an analysis of 811 patients. Br J Ophthalmol. 2019;103:725\u20139.","journal-title":"Br J Ophthalmol"},{"key":"4269_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-14777-8","volume":"12","author":"S Yoneyama","year":"2022","unstructured":"Yoneyama S, Fukui A, Sakurada Y, Terao N, Shijo T, Kusada N, et al. Distinct characteristics of central serous chorioretinopathy according to gender. Sci Rep. 2022;12:10565.","journal-title":"Sci Rep"},{"key":"4269_CR29","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41433-018-0163-7","volume":"32","author":"D Hanumunthadu","year":"2018","unstructured":"Hanumunthadu D, Van Dijk EHC, Gangakhedkar S, Goud A, Cheung CMG, Cherfan D, et al. Gender variation in central serous chorioretinopathy. Eye. 2018;32:1703\u20139.","journal-title":"Eye"},{"key":"4269_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1038\/s41433-023-02812-5","volume":"38","author":"NK Sahoo","year":"2024","unstructured":"Sahoo NK, Ong J, Selvam A, Brown R, Avdalimov M, Kulkarni A, et al. Gender differences in central serous chorioretinopathy based on the new multimodal imaging classification. Eye. 2024;38:964\u20137.","journal-title":"Eye"},{"key":"4269_CR31","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.preteyeres.2015.01.002","volume":"46","author":"JB Jonas","year":"2015","unstructured":"Jonas JB, Wang N, Yang D, Ritch R, Panda-Jonas S. Facts and myths of cerebrospinal fluid pressure for the physiology of the eye. Prog Retin Eye Res. 2015;46:67\u201383.","journal-title":"Prog Retin Eye Res"},{"key":"4269_CR32","doi-asserted-by":"publisher","first-page":"e29692","DOI":"10.1371\/journal.pone.0029692","volume":"7","author":"S Vurgese","year":"2012","unstructured":"Vurgese S, Panda-Jonas S, Jonas JB. Scleral thickness in human eyes. PLoS One. 2012;7:e29692.","journal-title":"PLoS One"},{"key":"4269_CR33","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.ajo.2009.04.029","volume":"148","author":"T Fujiwara","year":"2009","unstructured":"Fujiwara T, Imamura Y, Margolis R, Slakter JS, Spaide RF. Enhanced depth imaging optical coherence tomography of the choroid in highly myopic eyes. Am J Ophthalmol. 2009;148:445\u201350.","journal-title":"Am J Ophthalmol"},{"key":"4269_CR34","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1111\/aos.12891","volume":"94","author":"Y Li","year":"2016","unstructured":"Li Y, You QS, Wei WB, Xu J, Chen CX, Wang YX, et al. Prevalence and associations of central serous chorioretinopathy in elderly Chinese. The Beijing Eye Study 2011. Acta Ophthalmol. 2016;94:386\u201390.","journal-title":"Acta Ophthalmol"},{"key":"4269_CR35","doi-asserted-by":"crossref","unstructured":"Hasan N, Zarnegar A, Jacob N, Sahoo N, Saju S, Zhou A, et al. Clinical characteristics and progression of pachychoroid macular atrophy in central serous chorioretinopathy. Ophthalmol Retina. 2025;9:984\u201393.","DOI":"10.1016\/j.oret.2025.04.005"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04269-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04269-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T15:20:32Z","timestamp":1775661632000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04269-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,9]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4269"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04269-8","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,9]]},"assertion":[{"value":"25 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SP-J, RAJ, JBJ: European patent EP 3 271 392, JP 2021-119187, and U.S. Patent No. US 12,024,557 B2: \u201cAgents for use in the therapeutic or prophylactic treatment of myopia or hyperopia; European patent application 23196899.1\u201d. EGFR Antagonists for the treatment of diseases involving unwanted migration, proliferation, and metaplasia of RPE cells.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}